The Brighterside of News on MSN

New AI Tool Identifies Undiagnosed Alzheimer's Cases and Reduces Racial Gaps

Alzheimer’s disease touches millions of families across the United States and remains the most common neurodegenerative ...
National Academies of Sciences%2c Engineering%2c and Medicine

Alzheimer's Diagnostic Criteria Validation: Exploration of Next Steps - A Workshop

The Forum on Neuroscience and Nervous System Disorders hosted a public session at the 2011 Alzheimer's Association International Conference to identify a set of core principles that could be used to ...
KTLA

Global Momentum and Validation Grows at AAIC for ALZpath Proprietary pTau217 Antibody Use in Alzheimer's Disease Research, Diagnosis, and Treatment

ALZpath pTau217 antibody data included in 37 submissions at AAIC, building on 90 Publications Across 18 Countries demonstrating ALZpath's superior sensitivity and accuracy in blood-based tests for ...
Scientific Research Publishing

Early Alzheimer’s Disease Detection from Short Speech Samples Using Lightweight, Interpretable Linguistic Markers ()

Based Detection, Linguistic Biomarkers, Machine Learning, Explainable AI, Cognitive Decline Monitoring Share and Cite: de Filippis, R. and Al Foysal, A. (2025) Early Alzheimer’s Disease Detection from ...
Business Insider

Cumulus Neuroscience Completes Patient Enrollment for Pivotal CNS-101 Early-Stage Alzheimer's Dementia Validation Trial

Oxford and Cambridge Among Sites Participating in CNS-101 Validation Study BELFAST, Northern Ireland and CAMBRIDGE, Mass., May 31, 2023 /PRNewswire/ -- Cumulus Neuroscience (Cumulus; The Company), a ...
EurekAlert!

Davos Alzheimer’s Collaborative and pharmaceutical and diagnostics companies work together on Alzheimer’s disease blood biomarker validation

The Davos Alzheimer’s Collaborative (DAC), a pioneering worldwide initiative seeking to cure Alzheimer’s disease and improve brain health, today announced they will work with Janssen Research & ...
KTLA

Cumulus Neuroscience Completes Patient Enrollment for Pivotal CNS-101 Early-Stage Alzheimer's Dementia Validation Trial

BELFAST, Northern Ireland and CAMBRIDGE, Mass., May 31, 2023 /PRNewswire/ -- Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical ...